Share: Facebook Twitter LinkedIn
Activity Provided By:


Pharmacologic Treatment of ADPKD: Monitoring and Risk Mitigation

Access Activity

Overview / Abstract:

The advent of pharmacologic therapy for ADPKD offers new opportunities to delay the progression of renal decline for patients. However, health care providers need to know how to identify patients at high risk of progression when considering therapy and how to manage patients receiving disease-modifying therapy.

This is the third of three related activities on the pharmacologic management of patients with ADPKD. The activities follow a patient with ADPKD through her journey from diagnosis to consideration of therapy, initiation of treatment, and risk mitigation. In each 0.5-hour continuing education activity, internationally renowned faculty will provide key insights into assessing candidates for therapy, managing ongoing care, and employing strategies to mitigate risks. Additionally, a patient with ADPKD will provide a first-person perspective on the experience of undergoing treatment. This multimedia activity consists of a case study with text, faculty and patient videos, and evidence-based animated slides with narration. The activity is interactive, and the learner can advance through the material at their desired pace.


Feb 19, 2022


Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME



Credits / Hours




Presenters / Authors / Faculty

Neera Dahl, MD, PhD

Activity Specialities / Related Topics

Nephrology, Pharmacology, Primary Care

Sponsors / Supporters / Grant Providers

Otsuka America Pharmaceutical, Inc.

Keywords / Search Terms

CMEology CMEology, nephrologists, nephrology nurse practitioners, ADPKD, Physician, nurse, physician assistant, nephrology Free CE CME, primary care, primary care physicians Free CE CME

Access Activity

CORE Higher Education Group,, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the website or within our mobile apps.CORE Higher Education Group,, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the Terms of Service. Site Map